Affymax

Affymax EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Affymax (AFFY) as of Oct 10, 2026 is -38.02 M USD.

EBITDA

-38.02 MUSD

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Affymax is 2013 -38.02 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Affymax was 2012 - USD. It decreases by % lower compared to the previous year.

The Affymax EBITDA history

The Affymax EBITDA history
YEAREBITDAYoY
-38.02 MUSD—
Access this data via the Eulerpool API

Affymax Stock analysis

What does Affymax do? Affymax Inc is a leading biotechnology company specializing in the development of innovative therapeutics for patients with serious diseases. The company was founded in 2001 and is headquartered in Palo Alto, California. Affymax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Affymax stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Affymax is -38.02 M USD in 2013.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Affymax since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Affymax historically and in real time.

Access this data via the Eulerpool API

Income Statement — Affymax

All Key Metrics — Affymax